Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA® (pembrolizumab) as First-Line Treatment for PD-L1-Positive NSCLC Met Primary Endpoint

Last Updated On November 25, 2025

Get Up to 20% OFF

News

‘They’re all junk, and should be banned’: the trouble with at-home food intolerance tests

I’ve spent 20 years treading water and fear that I’ve wasted so much time. Am I depressed? | Ask Annalisa Barbieri

Why does alcohol make us both happy and miserable – and what else does it do to our minds and bodies?

My mother has been overpaid her civil service pension and ordered to repay it

‘Traceability is vital’: labs test thousands of unregulated substances amid peptide craze

Cars make way for bikes as Sydney commuters saddle up to circumvent ‘crazy’ fuel costs

2025-11-24 – Press Releases – www.prnewswire.com

CHENGDU, China, Nov. 24, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”, 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical study (OptiTROP-Lung05) of the company’s TROP2 ADC…

Read the full article here.

Get Up to 20% OFF

Related Feeds

SpaceGut’s Precision AI System for Gut Testing Achieves Up to 87% Improvement in Irritable Bowel Syndrome Management

Dark showering: is this the very best way to wash?

I can reach orgasm alone – but not with my partner

HIMSS APAC 2025: Malaysian Health Minister Visits GuidelineX Exhibition to Explore AI Clinical Decision Support System

‘A potential treasure trove’: World Health Organization to explore benefits of traditional medicines

Isokinetic exercise: What to know about this type of strength training

Is it true that … stretching before exercise prevents injury?

Cumulative social advantage: is this the secret to a long, happy, healthy life?

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma’s Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months

Advanced Aesthetic Technologies, Inc. is pleased to announce the approval of Algeness® VL agarose facial injection filler for marketing in China

Art could save your life! Five creative ways to make 2026 happier, healthier and more hopeful

The one change that worked: meditation cured my insomnia – and transformed my relationships

A controlling partner is isolating my daughter. What can I do to help?

World Gym Q3 Results: EPS Jumps 82.5% on Record Revenue

The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC

COMPANY

Mon-Fri 10 am to 7 pm.

Warehouse: (No Walk-In)

Scommerce, 1 Buroh Crescent #03-01
Cogent 1.Logistics Hub S(627545)

Qxpress, 30 Tuas West Rd, level 5, S (638386)

Wellness

The Quickest Weight Loss Exercises for an Attractive Body | Aerobic Dance Workout 2021 | Eva Fitness

Wellness

15min Fullbody Daily Stretch (Beginner routine l Flexibility & Mobility – At Home) l 15분 전신 스트레칭 루틴

Wellness

Your Home Is Full of Hidden Heavy Metals — Here’s the Superfood That Can Help Detoxify Your Body

Beauty

Having a Hard Time Removing Waterproof Mascara? This Pore Detox Remover Makes It Effortless

Beauty

Top Acne Skin Care Tips

Beauty

How to Build the Perfect Hydration Routine for Singapore Weather

All the content on this website, including medical opinion and any other health-related information, are solely to provide information only. Any information/statements on this blog are not intended to diagnose, treat, cure or prevent any disease, and should NOT be a substitute for health and medical advice that can be provided by your own physician/medical doctor. You should always consult a doctor before making any health or diet changes, especially any changes related to a specific diagnosis or condition.